Population
Rats fed a choline-deficient/L-amino acid-defined (CDAA) diet and isolated hepatic stellate cells
Comparison
Rho kinase inhibitor and angiotensin II receptor… vs Untreated CDAA-fed rats and untreated isolated…
Design
Preclinical
Authors
Loading...
Caution against clinical use in liver disease; leaves open Rho kinase inhibition as a target for human studies.
The Rho/Rho kinase pathway is involved in the renin-angiotensin system and plays a key role in hepatic fibrosis and steatosis, highlighting a potential therapeutic target.
Kitamura et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: